SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 41, Pages 5252-5263
Publisher
Springer Nature
Online
2015-01-26
DOI
10.1038/onc.2014.445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
- (2014) Matjaz Rokavec et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-24 Induces Apoptosis of Chronic Lymphocytic Leukemia B Cells Engaged into the Cell Cycle through Dephosphorylation of STAT3 and Stabilization of p53 Expression
- (2014) A. Sainz-Perez et al. JOURNAL OF IMMUNOLOGY
- Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways
- (2014) Hongsheng Lu et al. TUMOR BIOLOGY
- Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases
- (2013) Jong Hyun Lee et al. CANCER LETTERS
- Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma
- (2013) Wei-Tien Tai et al. HEPATOLOGY
- Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells
- (2013) Fei Luo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- SHP-1 in Cell-Cycle Regulation
- (2012) Pilar Lopez-Ruiz et al. Anti-Cancer Agents in Medicinal Chemistry
- Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
- (2012) Kuen-Feng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates Gα-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway
- (2011) Yash Mittal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
- (2011) Hua Xiong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- A Gαi–GIV Molecular Complex Binds Epidermal Growth Factor Receptor and Determines Whether Cells Migrate or Proliferate
- (2010) Pradipta Ghosh et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanisms of the epithelial–mesenchymal transition by TGF-β
- (2009) Michael K Wendt et al. Future Oncology
- GIV is a nonreceptor GEF for G i with a unique motif that regulates Akt signaling
- (2009) M. Garcia-Marcos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Sorafenib
- (2008) Dene Simpson et al. DRUGS
- Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2
- (2007) Ji-Hye Kang et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now